Article Text

Download PDFPDF

Somatostatin content and receptors in the cerebral cortex of depressed and control subjects.
  1. B G Charlton,
  2. A Leake,
  3. C Wright,
  4. A F Fairbairn,
  5. I G McKeith,
  6. J M Candy,
  7. I N Ferrier
  1. MRC Neuroendocrinology Unit, Newcastle General Hospital, Newcastle upon Tyne, UK.


    Somatostatin-like immunoreactivity is reduced in the cerebrospinal fluid in depression and this is presumed to reflect alterations in cerebral somatostatinergic systems. We have examined this hypothesis by measuring this immunoreactivity and somatostatin receptors in post-mortem cortical tissue from depressed patients and control subjects. There was no significant difference in the temporal and occipital cortex in somatostatin-like immunoreactivity or in somatostatin receptor affinity and binding capacity between depressed and control groups. It is concluded that there may not be an alteration of cortical somatostatin function in depression.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.